GHRP-6 Mechanism of Action — Research Reference
Ghrelin receptor agonism, central appetite-stimulating signal via NPY/AgRP neurons, and the secondary cortisol/prolactin profile distinguishing GHRP-6 in research.
GHRP-6 Mechanism of Action — Research Reference
GHRP-6 (His-D-Trp-Ala-Trp-D-Phe-Lys-NH2) was the first GHRP characterized in detail and remains a reference compound for ghrelin-receptor research. It is distinguished from ipamorelin and GHRP-2 by a prominent central appetite-stimulating signal.
Receptor Target
GHRP-6 is an agonist of the growth hormone secretagogue receptor type 1a (GHS-R1a). The receptor is expressed on pituitary somatotropes and on hypothalamic neurons regulating appetite — both populations are engaged at GH-effective doses.
Signal Transduction
GHS-R1a activation by GHRP-6 produces:
- Gαq/PLC-β/IP3 → intracellular Ca²⁺ release on somatotropes → GH-vesicle exocytosis.
- Gαs/cAMP/PKA → potentiation of GHRH signalling.
- Central NPY/AgRP neuron activation in the arcuate nucleus → robust appetite stimulation (the defining behavioural signature of GHRP-6 in rodent models).
Pharmacokinetics
Subcutaneous GHRP-6 reaches peak plasma in 15–30 minutes with a half-life of approximately 20–30 minutes. The D-amino acid scaffold confers peptidase resistance similar to other GHRPs.
Cortisol and Prolactin Effect
Like GHRP-2, GHRP-6 cross-activates corticotrope and lactotrope populations, producing acute ACTH and prolactin elevation. The magnitude is generally similar to GHRP-2 in published comparative studies.
Why the Appetite Signal Matters in Research
GHRP-6's central orexigenic effect makes it the most-cited GHRP in feeding-behaviour and ghrelin-pathway research — distinct from its GH-releasing role. Researchers focused purely on GH-pulse studies typically prefer ipamorelin or GHRP-2 to avoid the confounding appetite signal.
Research Use Only. All content is for laboratory research and educational reference. Compounds discussed are not intended for human or veterinary consumption.
References
- Bowers CY, Momany F, Reynolds GA, et al. Structure-activity relationships of a synthetic pentapeptide that specifically releases growth hormone in vitro. Endocrinology. 1980;106(3):663–667.
- Kojima M, Hosoda H, Date Y, et al. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature. 1999;402(6762):656–660.
- Wren AM, Small CJ, Ward HL, et al. The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion. Endocrinology. 2000;141(11):4325–4328.
Related Research Articles
GHRP-2 Mechanism of Action — Research Reference
Ghrelin receptor agonism, Gαq/PLC and Gαs/cAMP signalling, and the cross-pathway ACTH/prolactin elevation that distinguishes GHRP-2 from ipamorelin.
Hexarelin Mechanism of Action — Research Reference
GHS-R1a and CD36 dual binding, cardioprotective signalling pathways, and the high-potency GH pulse profile that defines hexarelin in research.
CJC-1295 Mechanism of Action — Research Reference
GHRH receptor agonism, Gαs/cAMP/PKA signalling, and the DAC albumin-binding chemistry that converts a 30-minute peptide into a multi-day depot.
Ipamorelin Mechanism of Action — Research Reference
Selective ghrelin/GHS-R1a agonism, Gαq/PLC and Gαs/cAMP signalling, and the receptor selectivity that explains ipamorelin's clean cortisol/prolactin profile.
Sermorelin Mechanism of Action — Research Reference
GHRH receptor binding, Gαs/cAMP signalling, and the short-half-life pulse-preserving profile that makes sermorelin the reference GHRH analogue.
GHK-Cu Mechanism of Action — Research Reference
Copper-coordination chemistry, gene-expression modulation, SOD/antioxidant activity, and matrix remodelling pathways defining GHK-Cu in tissue-repair research.
Related Research Materials
Parent Research Hubs
Neutral, moderated research discussion. Laboratory use only.
More compound guides, hubs, and educational research materials.